BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 20640860)

  • 1. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution.
    Hwang DW; Jang JY; Lee SE; Lim CS; Lee KU; Kim SW
    Langenbecks Arch Surg; 2012 Jan; 397(1):93-102. PubMed ID: 20640860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formula.
    Hwang DW; Jang JY; Lim CS; Lee SE; Yoon YS; Ahn YJ; Han HS; Kim SW; Kim SG; Yun YK; Han SS; Park SJ; Lim TJ; Kang KJ; Sim MS; Choi SH; Heo JS; Choi DW; Hur KY; Lee DS; Yun SS; Kim HJ; Cho CK; Kim HJ; Yu HC; Cho BH; Song IS
    J Korean Med Sci; 2011 Jun; 26(6):740-6. PubMed ID: 21655058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
    Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
    World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.
    Bournet B; Kirzin S; Carrère N; Portier G; Otal P; Selves J; Musso C; Suc B; Moreau J; Fourtanier G; Pradère B; Lazorthes F; Escourrou J; Buscail L
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1211-7. PubMed ID: 19476563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
    J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
    Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
    Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up.
    Uehara H; Ishikawa O; Katayama K; Kawada N; Ikezawa K; Fukutake N; Takakura R; Takano Y; Tanaka S; Takenaka A
    J Gastroenterol; 2011 May; 46(5):657-63. PubMed ID: 21085997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differentiated therapy for intraductal papillary mucinous neoplasms].
    Wente MN; Schmied BM; Schmidt J; Büchler MW
    Chirurg; 2009 Jan; 80(1):7-13. PubMed ID: 19082569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.
    Fan F; Lai EC; Xie F; Yang JM; Xu F; Kan T; Shen RX; Yang XY; Lau Wan Y; Wu MC
    Hepatogastroenterology; 2010; 57(99-100):635-9. PubMed ID: 20698241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas.
    Shin SH; Han DJ; Park KT; Kim YH; Park JB; Kim SC
    World J Surg; 2010 Apr; 34(4):776-83. PubMed ID: 20127242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Main-duct intraductal papillary mucinous adenoma of the pancreas.
    Takuma K; Kamisawa T; Tabata T; Kurata M; Honda G; Horiguchi S
    World J Surg Oncol; 2011 Nov; 9():153. PubMed ID: 22112163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of intraductal papillary mucinous neoplasm of the pancreas.
    Sugiyama M; Suzuki Y; Abe N; Mori T; Atomi Y
    J Gastroenterol; 2008; 43(3):181-5. PubMed ID: 18373159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm.
    Yamada S; Fujii T; Shimoyama Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
    Ann Surg Oncol; 2014 Jul; 21(7):2444-52. PubMed ID: 24562937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
    Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
    Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
    Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.